Bonesupport Holding AB
OTC:BOEUF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Bonesupport Holding AB
OTC:BOEUF
|
SE |
|
B
|
Biogen Inc
SWB:IDP
|
US |
|
B
|
Bayfirst Financial Corp
NASDAQ:BAFN
|
US |
|
C
|
CECO Environmental Corp
F:WCE
|
US |
|
AT&T Inc
NYSE:T
|
US |
|
Everlight Chemical Industrial Corp
TWSE:1711
|
TW |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BOEUF's stock price target?
Price Target
36.844
USD
According to Wall Street analysts, the average 1-year price target for 
BOEUF is 36.844 USD with a low forecast of 27.734 USD and a high forecast of 43.615 USD.
What is the Revenue forecast for Bonesupport Holding AB?
Projected CAGR
32%
Over the last 10 years, the compound annual growth rate for Revenue has been 34%. The projected CAGR for the next 5 years is 32%.
What is the Gross Profit forecast for Bonesupport Holding AB?
Projected CAGR
32%
Over the last 10 years, the compound annual growth rate for Gross Profit has been 35%. The projected CAGR for the next 5 years is 32%.
What is the Operating Income forecast for Bonesupport Holding AB?
Projected CAGR
66%
The compound annual growth rate for Operating Income over the next 5 years is 66%.
What is the Pre-Tax Income forecast for Bonesupport Holding AB?
Projected CAGR
63%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 63%.
What is the Net Income forecast for Bonesupport Holding AB?
Projected CAGR
64%
The compound annual growth rate for Net Income over the next 5 years is 64%.